相关实验视频
Updated: Sep 17, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.6K
帕金森病护理的未来:需要扩大获得的机会
Sana Aslam1, Anjail Z Sharrief2, Samantha K Holden1
1Department of Neurology, University of Colorado, Aurora, CO, United States.
Frontiers in neurology
|July 4, 2025
概括
对帕金森病 (PD) 患者来说,获得专门的运动障碍专家的机会是有限的,这影响了护理. 改善转诊途径和护理协调对于及时,先进的治疗机会至关重要.
科学领域:
- 神经学 神经学
- 医疗保健系统研究 医疗保健系统研究
背景情况:
- 帕金森病 (PD) 影响超过100万美国人,预计到2040年患病率将翻一番.
- 运动障碍专家 (MDS) 的专家护理改善了结果,但访问是有限的.
- 障碍阻碍了及时获得先进的PD治疗方法,如深度大脑刺激和输液疗法.
研究的目的:
- 解决帕金森病护理协调中的临床和系统层面的差距.
- 倡导改善向运动障碍专家的转诊途径.
- 提出提高获得PD专业护理的策略.
主要方法:
- 这是一篇透视性的文章,发出呼吁采取行动.
- 提出了改善转诊和护理协调的务实战略.
- 专注于识别和解决临床和系统层面的差距.
主要成果:
- 对于PD患者来说,有限的MDS接入是很重要的问题.
- 现有的转诊途径和护理协调不足.
- 及时获得先进疗法往往会延迟或错过.
结论:
- 标准化的转诊标准,临床决策工具,远程医疗,电子咨询和加强教育是建议的解决方案.
- 改善转诊途径和护理协调对于PD患者的治疗结果至关重要.
- 随着早期诊断技术的进步,对结构化转诊途径的需求将会加剧.
相关概念视频
Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
Parkinson's Disease: Overview
716
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
716
Patient-centered Care
2.3K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.3K
Peripheral Artery Disease III: Interprofessional Care
32
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
32
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265

